University Hospitals of Montpellier
Montpellier, 34925, France
NCT Number: NCT04526366
To date, no published systematic review and meta-analysis has compared AHI-CPAPflow and AHI-PSGgold. Therefore, the primary objective of this study is to compare published data for AHI-PSGgold and AHI-CPAPflow in patients treated by CPAP.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montpellier, 34925, France
The secondary objectives are to evaluate, in a manner similar to the primary objective, data for apnoea indices (AI), hypopnoea indices (HI), respiratory disturbance indices (RDI) and respiratory effort related arousals (RERAs) and to perform subgroup analyses focusing on the inclusion/exclusion of central apnoea patients, BMI levels, CPAP device brands, pressure titration modes, use of a predetermined and fixed pressure level or not, and the impact of a 4%-PSG desaturation criteria versus 3%-PSG on index accuracy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous Positive Airway Pressure device deployed for at least one night synchronously with polysomnography.
Polysomnography deployed for at least one night synchronously with Continuous Positive Airway Pressure.
Time frame: Day 0
AHI-CPAPflow = Apnoea-Hypopnoea-Indices Determined Via Continuous Positive Airway Pressure AHI-PSGgold = Apnoea-Hypopnoea-Indices Determined by Polysomnography
Time frame: Day 0
Time frame: Day 0
AI-CPAPflow = Apnoea--Indices Determined Via Continuous Positive Airway Pressure AI-PSGgold = Apnoea--Indices Determined by Polysomnography
Time frame: Day 0
Time frame: Day 0
HI-CPAPflow = Hypopnoea--Indices Determined Via Continuous Positive Airway Pressure HI-PSGgold = Hypopnoea--Indices Determined by Polysomnography
Time frame: Day 0
Time frame: Day 0
RDI-CPAPflow = Respiratory Disturbance Indices Determined Via Continuous Positive Airway Pressure RDI-PSGgold = Respiratory Disturbance Indices Determined by Polysomnography
Time frame: Day 0
Time frame: Day 0
RERA-CPAPflow = Respiratory Effort Related Arousals Determined Via Continuous Positive Airway Pressure RERA-PSGgold = Respiratory Effort Related Arousals Determined by Polysomnography
Time frame: Day 0
University Hospital, Montpellier
Other
Apnoea-Hypopnoea-Indices Determined Via Continuous Posi-tive Airway Pressure (AHI-CPAPflow) Versus Those Determined by Polysomnography (AHI-PSGgold): a Protocol for a Systematic Review and Meta-analysis
Acronym: Meta IAHflow
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06283017
Apnea, Dyssomnias
Adelaide, South Australia, Australia
View Trial DetailsNCT06627127
Apnea, Dyssomnias
Wollongong, New South Wales, Australia
View Trial DetailsNCT06283030
Apnea, Dyssomnias
Nashville, Tennessee, United States
View Trial DetailsNCT00743561
Apnea, Autonomic Nervous System Diseases
Bordeaux, France
View Trial Details